Business

Touting criticized study, White House presses FDA to authorize hydroxychloroquine — again

White House trade adviser Peter Navarro is leading a Trump administration effort to demand the Food and Drug Administration reverse course and grant a second emergency authorization for the antimalar…
Read More

Show More

Related Articles

Back to top button
Close
Close